MedPath

CO2 Laser and Open Surgery for T1N0 Glottic SCC With Anterior Commissure Involved

Not Applicable
Conditions
Squamous Cell Carcinoma of Glottis
Registration Number
NCT02303457
Lead Sponsor
Xuekui Liu
Brief Summary

Open surgery and CO2 laser surgery are both established treatment modalities for T1N0 glottic carcinoma. It is controversial for T1N0 glottic carcinoma with anterior commissure involved.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
402
Inclusion Criteria
  • T1N0 SCC of glottic carcinoma with anterior commissure involve
  • No nodal metastasis and distant metastasis
  • All patients must have CT/MR and electronic laryngoscope test before surgery and after surgery
  • Expected lifetime>1 year
  • Patients and families agreed to participate in the test and sign the informed consent
  • Without cognitive impairment.
Exclusion Criteria
  • With severe cardiac insufficiency Liver and kidney function is not complete systemic infection patients
  • Patients with pregnancy and lactation
  • Have surgery contraindications

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
disease-free survival5 years
Secondary Outcome Measures
NameTimeMethod
recurrence rate5 years

Trial Locations

Locations (1)

Sun Yat-sen University Cancer Center

🇨🇳

Guangzhou, Guangdong, China

Sun Yat-sen University Cancer Center
🇨🇳Guangzhou, Guangdong, China
xuekui liu, doctor
Contact
(86-20) 8734 3768
liuxk@sysucc.org.cn

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.